LOTUS PHARMACEUTICAL CO., LTD. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 270.50 TWD | -2.70% |
|
-1.28% | -0.55% |
Evolution of the Average Target: Lotus Pharmaceutical Co., Ltd.
Evolution of the Target Price: Lotus Pharmaceutical Co., Ltd.
Changes in Analyst Recommendations: Lotus Pharmaceutical Co., Ltd.
6755ac1657ec0f0bc.EMapF2LNtyu-9sNmjbfOBm4qdeQQM1dJXhs0fosMtJc.WqCcZi2F8En2vfMBz9j4TgF7RrNhURkRLyhxLdNTwcBfmexfEoDEWu3ApA~5550125a4ea3bafb36c75e78d84a83e5
| Analyst Opinion | 4m Revision of opinion | Divergence of analysts' opinions | Divergence of Target Price | Ecart obj. / dr | ||
|---|---|---|---|---|---|---|
| +45.95% | ||||||
| +7.16% | ||||||
| +8.65% | ||||||
| +3.55% | ||||||
| +0.88% | ||||||
| +21.20% | ||||||
| +10.86% | ||||||
| +14.91% | ||||||
| +1.49% | ||||||
| -1.60% | ||||||
| Average | +11.31% | |||||
| Weighted average by Cap. | +7.59% |
Analysts' Consensus
Sell
Buy
Mean consensus
BUY
Number of Analysts
5
Last Close Price
270.50TWD
Average target price
394.80TWD
Spread / Average Target
+45.95%
High Price Target
600.00TWD
Spread / Highest target
+121.81%
Low Price Target
330.00TWD
Spread / Lowest Target
+22.00%
Analyst Consensus Detail
Consensus revision (last 18 months)
Trading Rating
Investor Rating
ESG Refinitiv
- Stock Market
- Equities
- 1795 Stock
- Consensus Lotus Pharmaceutical Co., Ltd.
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition